Detalhes do Documento

Cardiac remodeling and dysfunction in nephrotic syndrome

Autor(es): Moreira-Rodrigues, M cv logo 1 ; Roncon-Albuquerque R, Jr. cv logo 2 ; Henriques-Coelho, T cv logo 3 ; Lourenço, AP cv logo 4 ; Sampaio-Maia, B cv logo 5 ; Santos, J cv logo 6 ; Pestana, M cv logo 7 ; Leite-Moreira, AF cv logo 8

Data: 2007

Identificador Persistente: http://hdl.handle.net/10216/67154

Origem: Repositório Aberto da Universidade do Porto


Descrição
There is an increased incidence of heart disease in patients with chronic nephrotic syndrome (NS), which may be attributable to the malnutrition and activated inflammatory state accompanying the sustained proteinuria. In this study, we evaluated renal function, cardiac morphometry, contractile function, and myocardial gene expression in the established puromycin aminonucleoside nephrosis rat model of NS. Two weeks after aminonucleoside injection, there was massive proteinuria, decreased creatinine clearance, and a negative sodium balance. Skeletal and cardiac muscle atrophy was present and was accompanied by impaired left ventricular (LV) hemodynamic function along with decreased contractile properties of isolated LV muscle strips. The expression of selected cytokines and proteins involved in calcium handling in myocardial tissue was evaluated by real time polymerase chain reaction. This revealed that the expression of interleukin-1beta, tumor necrosis factor-alpha, and phospholamban were elevated, whereas that of cardiac sarco(endo)plasmic reticulum calcium pump protein was decreased. We suggest that protein wasting and systemic inflammatory activation during NS contribute to cardiac remodeling and dysfunction.
Tipo de Documento Artigo
Idioma Inglês
delicious logo  facebook logo  linkedin logo  twitter logo 
degois logo
mendeley logo

Documentos Relacionados



    Financiadores do RCAAP

Fundação para a Ciência e a Tecnologia Universidade do Minho   Governo Português Ministério da Educação e Ciência Programa Operacional da Sociedade do Conhecimento União Europeia